Clinical Trial Update: Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rifaximin to norfloxacin in spontaneous bacterial peritonitis is ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Rifaximin (rifaximin)
• norofloxacin (norfloxacin)

Snippet

Sponsor: Ospedali Riuniti di Foggia | Conditions: Spontaneous Bacterial Peritonitis | Phase 3 | Status: UNKNOWN